Gene expression of CD14- cells from RA, PsA and PsO patients with Infliximab treatment

GSE57405

Homo sapiens

109 Downloadable Samples

Affymetrix HT HG-U133+ PM Array Plate (hthgu133pluspm)

Submitter Supplied Information

Description

objection: The immune inflammatory disorders rheumatoid arthritis (RA), psoriatic arthritis (PsA) and psoriasis (Ps) share common pathologic features and show responsiveness to anti-tumor necrosis factor (TNF) agents yet they are phenotypically distinct. The aim of this study was to examine if anti-TNF therapy is associated with divergent gene expression profiles in circulating cells and target tissues of patients with these diseases

PubMed ID

25333715

Publication Title

Divergent gene activation in peripheral blood and tissues of patients with rheumatoid arthritis, psoriatic arthritis and psoriasis following infliximab therapy.

Total Samples

111

Submitter’s Institution

University of Rochester Medical Center

Authors

Rosenberg A, Fan H, Chiu YG, Bolce R, Tabechian D, Barrett R, Moorehead S, Baribaud F, Liu H, Peffer N, Shealy D, Schwarz EM, Ritchlin CT

Source Repository

Gene Expression Omnibus (GEO)

Alternate Accession IDs

E-GEOD-57405

No rows found